Outlook Therapeutics, Inc. (OTLK) stock
OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$0.41+0.05 (+13.12%)
Close on Nov 18, 2026Market cap $99.30MP/E –Yield –
Outlook Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Outlook Therapeutics's market cap was $89.99M on Nov 11, 2026, against $96.46M a year earlier. Over the last 5 years it ranged from $13.29M to $446.60M, with a median of $124.92M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $89.99M | +5.7% |
| 2025 | Dec 31, 2025 | $85.14M | +88.4% |
| 2024 | Dec 31, 2024 | $45.18M | -55.9% |
| 2023 | Dec 29, 2023 | $102.54M | -58.2% |
| 2022 | Dec 30, 2022 | $245.50M | +2.3% |
| 2021 | Dec 31, 2021 | $239.99M | +45.1% |
| 2020 | Dec 31, 2020 | $165.34M | +879.5% |
| 2019 | Dec 31, 2019 | $16.88M | -53.3% |
| 2018 | Dec 31, 2018 | $36.11M | +11.4% |
| 2017 | Dec 29, 2017 | $32.41M | -52.8% |
| 2016 | Dec 30, 2016 | $68.64M | – |
See a number that looks wrong?